SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers
16 references·16 citing·30 second hopsampled
A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers (2006)A review of acute effects of 3,4-methylen…Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [11C]McN5652 and [11C]DASB (2005)Quantitative PET Studies of t…The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) (2003)The Pharmacology and Clinical…Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans (2002)Subjective and hormonal effec…3,4-Methylenedioxymethamphetamine (Ecstasy) and Alcohol Interactions in Humans: Psychomotor Performance, Subjective Effects, and Pharmacokinetics (2002)3,4-Methylenedioxymethampheta…Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies (2001)Which neuroreceptors mediate …Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research (2001)Human psychopharmacology of E…Gender differences in the subjective effects of MDMA (2001)Gender differences in the sub…Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons (2001)Effects of dose, sex, and lon…Cognitive performance and serotonergic function in users of ecstasy (2001)Cognitive performance and ser…Psychological and Physiological Effects of MDMA (“Ecstasy”) after Pretreatment with the 5-HT2 Antagonist Ketanserin in Healthy Humans (2000)Psychological and Physiologic…Human Pharmacology of 3,4-Methylenedioxymeth-amphetamine ("Ecstasy"): Psychomotor Performance and Subjective Effects (2000)Human Pharmacology of 3,4-Met…Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram (2000)Acute Psychological Effects o…(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals (2000)(±)3,4-Methylenedioxymethamph…Cardiovascular and Neuroendocrine Effects and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Humans (1999)Cardiovascular and Neuroendoc…Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers (1998)Psychological and Cardiovascu…MDMA (`ecstasy') consumption in the context of polydrug abuse: a report on 150 patients (1998)MDMA (`ecstasy') consumption …A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses (2020)A review of emerging therapeu…Safety pharmacology of acute MDMA administration in healthy subjects (2017)Safety pharmacology of acute …Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects (2017)Direct comparison of the acut…The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants? (2016)The effects of MDMA on socio-…MDMA and PTSD treatment (2016)MDMA and PTSD treatmentMDMA-assisted therapy: A new treatment model for social anxiety in autistic adults (2015)MDMA-assisted therapy: A new …A Window into the Intoxicated Mind? Speech as an Index of Psychoactive Drug Effects (2014)A Window into the Intoxicated…Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination (2013)Pharmacokinetic and pharmacod…MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational ‘Ecstasy’ users (2013)MDMA, serotonergic neurotoxic…Acute Prosocial Effects of Oxytocin and Vasopressin When Given Alone or in Combination with 3,4-Methylenedioxymethamphetamine in Rats: Involvement of the V1A Receptor (2013)Acute Prosocial Effects of Ox…3,4-methylenedioxymethamphetamine (MDMA): current perspectives (2013)3,4-methylenedioxymethampheta…Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses (2012)Therapeutic mechanisms of cla…Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users (2011)Linking the pharmacological c…A Psychobiological Rationale for Oxytocin in the Treatment of Posttraumatic Stress Disorder (2010)A Psychobiological Rationale …How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale (2009)How could MDMA (ecstasy) help…Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users (2008)Sustained effects of ecstasy …Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings (1998)3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings (2006)Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. (1987)Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity (2002)Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy (2005)Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms (2020)Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents (1984)Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)The Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans (1998)The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Connectivity (2014)The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals (2015)MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms? (2018)3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. (1987)Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. (1987)Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users (2000)Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview (2009)Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens (1986)Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis (1997)Ecstasy (MDMA): a review of its possible persistent psychological effects (2000)A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD) (2012)STAI manual for the State-trait anxiety inventory (1970)Effects of MDMA on sociability and neural response to social threat and social reward (2009)Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others (2010)Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects (2019)MDMA enhances emotional empathy and prosocial behavior (2013)RETRACTED ARTICLE: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials (2019)Effect of illicit recreational drugs upon sleep: Cocaine, ecstasy and marijuana (2008)The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers (2014)Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms (2003)Cerebellar Volumes in Pediatric Maltreatment-Related Posttraumatic Stress Disorder (2006)
this work references cited by second hop· second hop is a sample of the most-cited connections

References

  • 2003The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)1,271 cited
  • 1998Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers448 cited
  • 1999Cardiovascular and Neuroendocrine Effects and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Humans362 cited
  • 2001Gender differences in the subjective effects of MDMA359 cited
  • 2001Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research344 cited
  • 2000(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals292 cited
  • 2001Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons251 cited
  • 2000Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram248 cited
  • 2000Psychological and Physiological Effects of MDMA (“Ecstasy”) after Pretreatment with the 5-HT2 Antagonist Ketanserin in Healthy Humans245 cited
  • 2001Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies236 cited
  • 2000Human Pharmacology of 3,4-Methylenedioxymeth-amphetamine ("Ecstasy"): Psychomotor Performance and Subjective Effects234 cited
  • 2001Cognitive performance and serotonergic function in users of ecstasy233 cited
  • 2002Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

229 cited
  • 1998MDMA (`ecstasy') consumption in the context of polydrug abuse: a report on 150 patients216 cited
  • 2005Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [11C]McN5652 and [11C]DASB204 cited
  • 20023,4-Methylenedioxymethamphetamine (Ecstasy) and Alcohol Interactions in Humans: Psychomotor Performance, Subjective Effects, and Pharmacokinetics191 cited
  • Cited by

    • 2017Safety pharmacology of acute MDMA administration in healthy subjects146 cited
    • 2010A Psychobiological Rationale for Oxytocin in the Treatment of Posttraumatic Stress Disorder135 cited
    • 2013Acute Prosocial Effects of Oxytocin and Vasopressin When Given Alone or in Combination with 3,4-Methylenedioxymethamphetamine in Rats: Involvement of the V1A Receptor128 cited
    • 2013Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination126 cited
    • 2012Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses125 cited
    • 2013MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational ‘Ecstasy’ users118 cited
    • 2017Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects117 cited
    • 2015MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults110 cited
    • 2016The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?105 cited
    • 2016MDMA and PTSD treatment97 cited
    • 2009How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale96 cited
    • 2020A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses95 cited
    • 20133,4-methylenedioxymethamphetamine (MDMA): current perspectives93 cited
    • 2008Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users93 cited
    • 2011Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users89 cited
    • 2014A Window into the Intoxicated Mind? Speech as an Index of Psychoactive Drug Effects88 cited